Low bone mineral density in chinese adults with nonalcoholic fatty liver disease

International Journal of Endocrinology

Volumn 2013, Issue , 2013, Pages

  Cui, Ran ^a   Sheng, Hui ^a   Rui, Xue Fei ^a   Cheng, Xiao Yun ^a   Sheng, Chun Jun ^a   Wang, Ji Ying ^a   Qu, Shen ^a  

^a TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; HIGH DENSITY LIPOPROTEIN; OSTEOCALCIN; VITAMIN D;

ADULT; AGED; ARTICLE; BODY MASS; BODY WEIGHT; BONE DENSITY; BONE DISEASE; BONE METABOLISM; CELL FUNCTION; CHINA; CHINESE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; FEMUR NECK; HIP; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; OBESITY; PANCREAS ISLET BETA CELL; POSTMENOPAUSE; PRIORITY JOURNAL; WAIST CIRCUMFERENCE;

EID: 84883170514     PISSN: 16878337     EISSN: 16878345     Source Type: Journal    
DOI: 10.1155/2013/396545     Document Type: Article

References (32)

1. Moon S.-S., Lee Y.-S., Kim S. W., Association of nonalcoholic fatty liver disease with low bone mass in postmenopausal women. Endocrine 2012 42 2 423 429 2-s2.0-84857832253 10.1007/s12020-012-9639-6
2. Pardee P. E., Dunn W., Schwimmer J. B., Non-alcoholic fatty liver disease is associated with low bone mineral density in obese children. Alimentary Pharmacology and Therapeutics 2012 35 2 248 254 2-s2.0-83855161556 10.1111/j.1365-2036.2011.04924.x
3. Hapses S. A., Sukumar D., Bone metabolism in obesity and weight loss. Annual Review of Nutrition 2012 32 287 309
4. Arikan S., Tuzcu A., Bahceci M., Ozmen S., Gokalp D., Insulin resistance in type 2 diabetes mellitus may be related to bone mineral density. Journal of Clinical Densitometry 2012 15 2 186 190 2-s2.0-84860431976 10.1016/j.jocd.2011. 11.005
5. Faulhaber G. A. M., Premaor M. O., Moser Filho H. L., Silla L. M., Furlanetto T. W., Low bone mineral density is associated with insulin resistance in bone marrow transplant subjects. Bone Marrow Transplantation 2009 43 12 953 957 2-s2.0-67649834083 10.1038/bmt.2009.70
6. Aller R., Castrillon J. L. P., de Luis D. A., Conde R., Izaola O., Sagrado M. G., Velasco M. C., Alvarez T., Pacheco D., Relation of osteocalcin with insulin resistance and histopathological changes of non alcoholic fatty liver disease. Annals of Hepatology 2011 10 1 50 55 2-s2.0-79956034859
7. Yilmaz Y., Kurt R., Eren F., Imeryuz N., Serum osteocalcin levels in patients with nonalcoholic fatty liver disease: association with ballooning degeneration. Scandinavian Journal of Clinical and Laboratory Investigation 2011 71 8 631 636 2-s2.0-81255143210 10.3109/00365513.2011.604427
8. Byrne C. D., Olufad R., Bruce K. D., Cagampang F. R., Ahmed M. H., Metabolic disturbances in non-alcoholic fatty liver disease. Clinical Science 2009 116 7 539 564 2-s2.0-65549122652 10.1042/CS20080253
9. Li M., Xu Y., Xu M., Association between nonalcoholic fatty liver disease (NAFLD) and osteoporotic fracture in middle-aged and elderly Chinese. The Journal of Clinical Endocrinology & Metabolism 2012 97 6 2033 2038
10. Hall A. M., Kou K., Chen Z., Pietka T. A., Kumar M., Korenblat K. M., Lee K., Ahn K., Fabbrini E., Klein S., Goodwin B., Finck B. N., Evidence for regulated monoacylglycerol acyltransferase expression and activity in human liver. Journal of Lipid Research 2012 53 5 990 999 2-s2.0-84860280975 10.1194/jlr.P025536
11. Tarantino G., Finelli C., Colao A., Capone D., Tarantino M., Grimaldi E., Chianese D., Gioia S., Pasanisi F., Contaldo F., Scopacasa F., Savastano S., Are hepatic steatosis and carotid intima media thickness associated in obese patients with normal or slightly elevated gamma-glutamyl-transferase? Journal of Translational Medicine 2012 10 1, article 50 2-s2.0-84858174466 10.1186/1479-5876-10-50
12. Savastano S., Di Somma C., Pizza G., De Rosa A., Nedi V., Rossi A., Orio F., Lombardi G., Colao A., Tarantino G., Liver-spleen axis, insulin-like growth factor-(IGF)-I axis and fat mass in overweight/obese females. Journal of Translational Medicine 2011 9 1, article 136 2-s2.0-80051615349 10.1186/1479-5876-9-136
13. Tarantino G., Caputi A., JNKs, insulin resistance and inflammation: a possible link between NAFLD and coronary artery disease. World Journal of Gastroenterology 2011 17 33 3785 3794 2-s2.0-80053910309 10.3748/wjg.v17.i33. 3785
14. Judex S., Carlson K. J., Is bone's response to mechanical signals dominated by gravitational loading? Medicine and Science in Sports and Exercise 2009 41 11 2037 2043 2-s2.0-70350217938 10.1249/MSS.0b013e3181a8c6e5
15. Holecki M., Chudek J., Titz-Bober M., Wiecek A., Zahorska-Markiewicz B., Dulawa J., Changes of bone mineral density in obese perimenopausal women during 5-year follow-up. Polskie Archiwum Medycyny Wewne 2012 122 4 139 147
16. Hoy C. L., Macdonald H. M., McKay H. A., How does bone quality differ between healthy-weight and overweight adolescents and young adults? Clinical Orthopaedics and Related Research 2013 471 4 1214 1225
17. Greco E. A., Francomano D., Fornari R., Negative association between trunk fat, insulin resistance and skeleton in obese women. World Journal of Diabetes 2013 4 2 31 39
18. Arikan S., Tuzcu A., Bahceci M., Ozmen S., Gokalp D., Insulin resistance in type 2 diabetes mellitus may be related to bone mineral density. Journal of Clinical Densitometry 2012 15 2 186 190 2-s2.0-84860431976 10.1016/j.jocd.2011. 11.005
19. Ishii S., Cauley J. A., Crandall C. J., Srikanthan P., Greendale G. A., Huang M.-H., Danielson M. E., Karlamangla A. S., Diabetes and femoral neck strength: findings from the hip strength across the menopausal transition study. Journal of Clinical Endocrinology and Metabolism 2012 97 1 190 197 2-s2.0-84855476226 10.1210/jc.2011-1883
20. Sun H. B., Chen J. C., Prevention of bone loss by injection of insulin-like growth factor-1 after sciatic neurectomy in rats. Chinese Journal of Traumatology 2013 16 3 158 162
21. Tarantino G., Savastano S., Colao A., Hepatic steatosis, low-grade chronic inflammation and hormone/growth factor/adipokine imbalance. World Journal of Gastroenterology 2010 16 38 4773 4783 2-s2.0-78049503241 10.3748/wjg.v16.i38.4773
22. Pramojanee S. N., Phimphilai M., Kumphune S., Chattipakorn N., Chattipakorn S. C., Decreased jaw bone density and osteoblastic insulin signaling in a model of obesity. Journal of Dental Research 2013 92 6 560 565 10.1177/0022034513485600
23. Fernández-Real J. M., Puig J., Serrano M., Iron and obesity status-associated insulin resistance influence circulating fibroblast-growth factor-23 concentrations. PLoS ONE 2013 8 3 e58961.
24. Wang R., Lu Q., Feng J., Yin F., Qin C., Liu B., Liu Y., Liu X., Coexistence of non-alcoholic fatty liver disease with elevated alanine aminotransferase is associated with insulin resistance in young Han males. Endocrine 2011 41 70 75 2-s2.0-79960687853 10.1007/s12020-011-9511-0
25. Tarantino G., Colao A., Capone D., Conca P., Tarantino M., Grimaldi E., Chianese D., Finelli C., Contaldo F., Scopacasa F., Savastano S., Circulating levels of cytochrome C, gamma-glutamyl transferase, triglycerides and unconjugated bilirubin in overweight/obese patients with non-alcoholic fatty liver disease. Journal of Biological Regulators and Homeostatic Agents 2011 25 1 47 56 2-s2.0-79955700474
26. Purnak T., Beyazit Y., Ozaslan E., Efe C., Hayretci M., The evaluation of bone mineral density in patients with nonalcoholic fatty liver disease. Wien Klin Wochenschr 2012 124 15526 16531
27. Ferron M., Hinoi E., Karsenty G., Ducy P., Osteocalcin differentially regulates β cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice. Proceedings of the National Academy of Sciences of the United States of America 2008 105 13 5266 5270 2-s2.0-42449096306 10.1073/pnas.0711119105
28. Iki M., Tamaki J., Fujita Y., Kouda K., Yura A., Kadowaki E., Sato Y., Moon J. S., Tomioka K., Okamoto N., Kurumatani N., Serum undercarboxylated osteocalcin levels are inversely associated with glycemic status and insulin resistance in an elderly Japanese male population: fujiwara-kyo Osteoporosis Risk in Men (FORMEN) Study. Osteoporosis International 2012 23 2 761 770 2-s2.0-84857367753 10.1007/s00198-011-1600-7
29. Yilmaz Y., Review article: non-alcoholic fatty liver disease and osteoporosis-clinical and molecular crosstalk. Pharmacology & Therapeutics 2012 36 4 345 352
30. Lee S., Clark S. A., Gill R. K., Christakos S., 1,25-Dihydroxyvitamin D3 and pancreatic β -cell function: vitamin D receptors, gene expression, and insulin secretion. Endocrinology 1994 134 4 1602 1610 2-s2.0-0028180723 10.1210/en.134.4.1602
31. Lips P., Vitamin D physiology. Progress in Biophysics and Molecular Biology 2006 92 4 8
32. Targher G., Bertolini L., Scala L., Cigolini M., Zenari L., Falezza G., Arcaro G., Associations between serum 25-hydroxyvitamin D3 concentrations and liver histology in patients with non-alcoholic fatty liver disease. Nutrition, Metabolism and Cardiovascular Diseases 2007 17 7 517 524 2-s2.0-34547485376 10.1016/j.numecd.2006.04.002